Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis.
Lamassu Pharma has raised $2.7M in total funding. The most recent round was Grant. The last funding was announced in June 2025.
Lamassu Pharma's investors include National Institutes of Health, National Cancer Institute.
Lamassu Pharma is headquartered in Durham, United States.
Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis.
Lamassu Pharma is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lamassu Pharma — Funding & Investors." VCBacked, June 3, 2025, https://www.vcbacked.co/company/lamassu-pharma. Accessed October 17, 2026.
VCBacked. (2025). Lamassu Pharma — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/lamassu-pharma
{{cite web |title=Lamassu Pharma — Funding & Investors |url=https://www.vcbacked.co/company/lamassu-pharma |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated